tiprankstipranks
Trending News
More News >
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market

Bone Biologics (BBLG) Income Statement

Compare
93 Followers

Bone Biologics Income Statement

Last quarter (Q4 2025), Bone Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Bone Biologics's net income was $-684.64K. See Bone Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 3.23M$ 4.22M$ 9.43M$ 3.67M$ 1.10M
Depreciation and Amortization
$ 0.00$ 4.22M$ 9.43M$ 0.00$ 0.00
EBITDA
$ -3.11M$ 107.16K$ 479.57K$ -752.91K$ -805.58K
Operating Income
$ -3.23M$ -4.22M$ -9.43M$ -3.67M$ -1.10M
Other Income/Expenses
$ 125.95K$ 106.74K$ 479.57K$ 2.18M$ -507.61K
Pretax Income
$ -3.11M$ -4.11M$ -8.95M$ -1.48M$ -1.61M
Net Income
$ -3.11M$ -4.11M$ -8.95M$ -1.48M$ -1.61M
Per Share Metrics
Basic EPS
$ -2.65$ -4.83$ -34.01$ -31.15$ -37.35
Diluted EPS
$ -2.65$ -4.83$ -34.01$ -31.20$ -37.35
Weighted Average Shares Outstanding
1.17M 1.52M 263.14K 47.60K 43.00K
Weighted Average Shares Outstanding (Diluted)
1.17M 1.52M 263.14K 47.66K 43.13K
Currency in USD

Bone Biologics Earnings and Revenue History